TSTakashi Satoh

Takashi Satoh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Takashi Satoh has a total of 107 co-authors. Here are the top co-authors by number of shared publications:

  • Shizuo Akira

    Innate Cell Therapy Inc., Osaka 530-0017, Japan; Laboratory of Host Defense, World Premier Institute Immunology Frontier Research Center, WPI-IFReC, Osaka University, Osaka 565-0871, Japan

    6 shared publications
  • Yuichi Mitsui

    Department of Immunology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan

    5 shared publications
  • Junya Watanabe

    Department of Immunology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan

    4 shared publications
  • Kanako Kuniyoshi

    Department of Immunology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo 113-8510, Japan

    4 shared publications
  • Masahito Ikawa

    Department of Experimental Genome Research, Research Institute for Microbial Diseases, The University of Osaka

    4 shared publications
  • Seiya Oba

    Department of Rheumatology, Tokyo Medical and Dental University (TMDU), Tokyo 113-8510, Japan

    4 shared publications

Latest Publications

  • Loss of Actrt1 in non-hematopoietic stroma suppresses pathological angiogenesis and tumor progression

    by Mariko Komuro, Yuichi Mitsui, Mio Edamoto, Junya Watanabe, Yuto Nagashima, Hisamichi Naito, Masahito Ikawa, Takashi Satoh

  • Open Access

    Functional diversity of disorder-specific macrophages involved in various diseases

    by Yuichi Mitsui, Takashi Satoh

    Macrophages are highly plastic immune cells that adopt diverse functional states in response to the local microenvironment. The traditional M1/M2 polarization model that has long been used to describe macrophage activation is insufficient to capture the full spectrum of macrophage diversity observed in vivo. Advances in single-cell RNA sequencing (scRNA-seq) have revealed that macrophages exist in a continuum of transcriptional states formed by tissue-specific and disorder-specific cues. This insight has led to the recognition of disorder-specific macrophages, defined as macrophage subpopulations that emerge in response to pathological stimuli and play unique roles in disease progression. These macrophages exhibit distinct transcriptional signatures, epigenetic modifications, and functional properties shaped by their ontogeny and microenvironmental signals, arising from the reprogramming of resident macrophages or the differentiation of bone marrow–derived progenitors. Notable examples include macrophages in chronic infections (e.g., tuberculosis), immunosuppressive tumor-associated macrophages, lipid-associated macrophages in obesity, and disease-associated microglia in neurodegeneration. These subsets exhibit unique regulatory mechanisms, including enhancer remodeling driven by histone H3 lysine 27 acetylation in non-alcoholic steatohepatitis, CCAAT enhancer binding protein α-mediated differentiation in obesity, and Jmjd3-IRF4 axis control in allergic inflammation. Additionally, their function and fate are strongly influenced by their subtissular niche, as evidenced by crown-like structures in adipose tissue, tumor microenvironments, fibrotic lesions, and granulomas, where distinct microenvironmental cues shape macrophage behavior. Furthermore, interindividual heterogeneity in macrophage function, driven by genetic polymorphisms, is increasingly recognized, highlighting the role of host genetic background in disease susceptibility and macrophage-driven pathology. Here, we review the conceptual evolution of the disorder-specific macrophage, tracing its origins from the limited M1/M2 model to its refinement through scRNA-seq-based classification. We summarize the ontogeny, transcriptional regulation, and spatial heterogeneity of these macrophages across various disorders, emphasizing how the subtissular niche dictates functional specialization. Finally, we discuss potential therapeutic strategies targeting disorder-specific macrophage subsets, highlighting the need for integrative multi-omics approaches to refine their classification and functional characterization. Understanding the regulatory networks that govern disorder-specific macrophages will advance our knowledge of macrophage biology while facilitating the development of precision medicine for immune-related disorders.


  • Expression of the readthrough transcript CiDRE in alveolar macrophages boosts SARS-CoV-2 susceptibility and promotes COVID-19 severity

    by Yuichi Mitsui, Tatsuya Suzuki, Kanako Kuniyoshi, Jun Inamo, Kensuke Yamaguchi, Mariko Komuro, Junya Watanabe, Mio Edamoto, Songling Li, Tsukasa Kouno, et al.


  • Open Access

    疾患特異的マクロファージの機能的多様性

    by Takashi Satoh

    マクロファージはその発見以来100年以上もの間,一種類の細胞しかないと考えられており,サブタイプが複数ある他の免疫細胞と比較すると日陰の存在であった.しかし近年,徐々に再度スポットライトが当てられ始めている.その中でも,最近のトピックの1つとして,M1・M2マクロファージが挙げられる.しかし,私たちはマクロファージはM1・M2ではなく更に詳細なサブタイプに分かれると仮定して研究を行った.その結果,アレルギーに関わるサブタイプはJmjd3により分化すること,またメタボリックシンドロームに関与するサブタイプはTrib1より分化することを突き止めた.これらの研究から,現在私たちは病気ごとの“疾患特異的マクロファージ”が存在している可能性を考えている.新たな疾患特異的マクロファージを探索するために,線維症に着目した.線維化初期に患部で増えるマクロファージについて解析を行ったところ,一部の細胞が線維症の発症に必須であることを突き止め,segregated nucleus atypical monocyte(SatM)と名付けた.さらに,この細胞に影響を与える非免疫系の解析,またその非免疫系の制御因子の研究を行ってきた.このように,私たちの体には未だ見つかっていない“疾患特異的マクロファージ”が存在しており,各々が対応する疾患が存在していると考えられる.これらの疾患特異的な細胞を標的とした創薬は,その疾患特異性の高さから,副作用の少ない創薬応用につながることが期待される.


  • Open Access

    Apple-shaped obesity: A risky soil for cytokine-accelerated severity in COVID-19

    by Tadashi Hosoya, Seiya Oba, Yoji Komiya, Daisuke Kawata, Mari Kamiya, Hideyuki Iwai, Sho Miyamoto, Michiyo Kataoka, Minoru Tobiume, Takayuki Kanno, et al.

    Obesity has been recognized as one of the most significant risk factors for the deterioration and mortality associated with COVID-19, but the significance of obesity itself differs among ethnicity. Multifactored analysis of our single institute–based retrospective cohort revealed that high visceral adipose tissue (VAT) burden, but not other obesity-associated markers, was related to accelerated inflammatory responses and the mortality of Japanese COVID-19 patients. To elucidate the mechanisms how VAT-dominant obesity induces severe inflammation after severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection, we infected two different strains of obese mice, C57BL/6JHamSlc-ob/ob (ob/ob), C57BLKS/J-db/db (db/db), genetically impaired in the leptin ligand and receptor, respectively, and control C57BL/6 mice with mouse-adapted SARS-CoV-2. Here, we revealed that VAT-dominant ob/ob mice were extremely more vulnerable to SARS-CoV-2 due to excessive inflammatory responses when compared to SAT-dominant db/db mice. In fact, SARS-CoV-2 genome and proteins were more abundant in the lungs of ob/ob mice, engulfed in macrophages, resulting in increased cytokine production including interleukin (IL)-6. Both an anti-IL-6 receptor antibody treatment and the prevention of obesity by leptin replenishment improved the survival of SARS-CoV-2-infected ob/ob mice by reducing the viral protein burden and excessive immune responses. Our results have proposed unique insights and clues on how obesity increases the risk of cytokine storm and death in patients with COVID-19. Moreover, earlier administration of antiinflammatory therapeutics including anti-IL-6R antibody to VAT-dominant patients might improve clinical outcome and stratification of the treatment for COVID-19, at least in Japanese patients.


  • TDAG51 promotes transcription factor FoxO1 activity during LPS‐induced inflammatory responses

    by Eui‐Soon Park, Hyoeun Jeon, Nari Lee, Jiyeon Yu, Hye‐Won Park, Takashi Satoh, Shizuo Akira, Tatsuo Furuyama, Chul‐Ho Lee, Jong‐Soon Choi, et al.

    Tight regulation of Toll-like receptor (TLR)-mediated inflammatory responses is important for innate immunity. Here, we show that T-cell death-associated gene 51 (TDAG51/PHLDA1) is a novel regulator of the transcription factor FoxO1, regulating inflammatory mediator production in the lipopolysaccharide (LPS)-induced inflammatory response. TDAG51 induction by LPS stimulation was mediated by the TLR2/4 signaling pathway in bone marrow-derived macrophages (BMMs). LPS-induced inflammatory mediator production was significantly decreased in TDAG51-deficient BMMs. In TDAG51-deficient mice, LPS- or pathogenic Escherichia coli infection-induced lethal shock was reduced by decreasing serum proinflammatory cytokine levels. The recruitment of 14-3-3ζ to FoxO1 was competitively inhibited by the TDAG51-FoxO1 interaction, leading to blockade of FoxO1 cytoplasmic translocation and thereby strengthening FoxO1 nuclear accumulation. TDAG51/FoxO1 double-deficient BMMs showed significantly reduced inflammatory mediator production compared with TDAG51- or FoxO1-deficient BMMs. TDAG51/FoxO1 double deficiency protected mice against LPS- or pathogenic E. coli infection-induced lethal shock by weakening the systemic inflammatory response. Thus, these results indicate that TDAG51 acts as a regulator of the transcription factor FoxO1, leading to strengthened FoxO1 activity in the LPS-induced inflammatory response.


  • Open Access

    CiDRE + M2c macrophages hijacked by SARS-CoV-2 cause COVID-19 severity

    by Yuichi Mitsui, Tatsuya Suzuki, Kanako Kuniyoshi, Jun Inamo, Kensuke Yamaguchi, Mariko Komuro, Junya Watanabe, Mio Edamoto, Songling Li, Tsukasa Kouno, et al.

    Infection of the lungs with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) via the angiotensin I converting enzyme 2 (ACE2) receptor induces a type of systemic inflammation known as a cytokine storm. However, the precise mechanisms involved in severe coronavirus disease 2019 (COVID-19) pneumonia are unknown. Here, we show that interleukin-10 (IL-10) changed normal alveolar macrophages into ACE2-expressing M2c-type macrophages that functioned as spreading vectors for SARS-CoV-2 infection. The depletion of alveolar macrophages and blockade of IL-10 attenuated SARS-CoV-2 pathogenicity. Furthermore, genome-wide association and quantitative trait locus analyses identified novel mRNA transcripts in human patients, COVID-19 infectivity enhancing dual receptor (CiDRE), which has unique synergistic effects within the IL-10-ACE2 system in M2c-type macrophages. Our results demonstrate that alveolar macrophages stimulated by IL-10 are key players in severe COVID-19. Collectively, CiDRE expression levels are potential risk factors that predict COVID-19 severity, and CiDRE inhibitors might be useful as COVID-19 therapies. Graphical


  • Open Access

    Trim41 is required to regulate chromosome axis protein dynamics and meiosis in male mice

    by Seiya Oura, Toshiaki Hino, Takashi Satoh, Taichi Noda, Takayuki Koyano, Ayako Isotani, Makoto Matsuyama, Shizuo Akira, Kei-Ichiro Ishiguro, Masahito Ikawa

    Meiosis is a hallmark event in germ cell development that accompanies sequential events executed by numerous molecules. Therefore, characterization of these factors is one of the best strategies to clarify the mechanism of meiosis. Here, we report tripartite motif-containing 41 (TRIM41), a ubiquitin ligase E3, as an essential factor for proper meiotic progression and fertility in male mice. Trim41 knockout (KO) spermatocytes exhibited synaptonemal complex protein 3 (SYCP3) overloading, especially on the X chromosome. Furthermore, mutant mice lacking the RING domain of TRIM41, required for the ubiquitin ligase E3 activity, phenocopied Trim41 KO mice. We then examined the behavior of mutant TRIM41 (ΔRING-TRIM41) and found that ΔRING-TRIM41 accumulated on the chromosome axes with overloaded SYCP3. This result suggested that TRIM41 exerts its function on the chromosome axes. Our study revealed that Trim41 is essential for preventing SYCP3 overloading, suggesting a TRIM41-mediated mechanism for regulating chromosome axis protein dynamics during male meiotic progression.


  • Open Access

    CiDRE M2c Macrophages Hijacked by SARS-CoV-2 Cause COVID-19 Severity

    by Yuichi Mitsui, Tatsuya Suzuki, Kanako Kuniyoshi, Mariko Komuro, Junya Watanabe, Mio Edamoto, Seiya Oba, Tadashi Hosoya, Shinsuke Yasuda, Yasunari Miyazaki, et al.

    Infection of the lungs with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) via the angiotensin I converting enzyme 2 (ACE2) receptor induces a cytokine storm. However, the precise mechanisms involved in severe coronavirus disease 2019 (COVID-19) pneumonia are unknown. Here, we show that interleukin-10 (IL-10) changed normal alveolar macrophages into ACE2-expressing M2c-type macrophages that functioned as spreading vectors for SARS-CoV-2 infection. The inhibition of this system attenuated SARS-CoV-2 pathogenicity. Furthermore, genome-wide association and quantitative trait locus analyses identified novel mRNA transcripts, COVID-19 infectivity enhancing dual receptor (CiDRE), are highly expressed in patients harboring COVID-19 risk variants in the IFNAR2/IL10RB locus. This unique receptor has synergistic effects within the IL-10-ACE2 system in macrophages and works as a decoy receptor for type I interferon. Collectively, the IL-10 concentration and CiDRE expression levels are potential risk factors that predict COVID-19 severity and IL-10R and CiDRE inhibitors might be useful COVID-19 therapies. Funding Information: This work was supported by Innate Cell Therapy Co., Ltd. This work was supported by the Japan Science and Technology Agency (JST) by funding with a Grant-in-Aid for Transformative Research Areas B (22H05060 and 22H05061) and Grant-in-Aid for Scientific Research on Innovative Areas (18H05032). This work was supported by the Japan Agency for Medical Research and Development (AMED); Research Program Immunology and Allergy under grant number 21ek0410083h0002 and the Research Program on Hepatitis (18fk0310106h0002 and 18fk0210041h0001). This work was also supported by the Takeda Hosho Grants for Research in Medicine and the Visionary Research Fund from the Takeda Science Foundation, JST Moonshot R&D under Grant Number JPMJMS2024, Grant-in-Aids for Scientific Research (B) (22H02597), Grant-in-Aid for Challenging Research (21K19501) from the MEXT of Japan, and a grant from Medical Research Center Initiative for High Depth Omics. Declaration of Interests: The authors declare no competing interests. Ethics Approval Statement: The study protocols were approved by the ethical committees of Tokyo Medical and Dental University (A2021-275C and A2021-294A). All animal experiments with SARS-CoV-2 were performed in Animal Biosafety Level 3 (ABSL3) facilities at the Research Institute for Microbial Diseases, Osaka University. The study protocols were approved by the Institutional Committee of Laboratory Animal Experimentation of the Research Institute for Microbial Diseases, Osaka University (R02-08-0). All efforts were made during the study to minimize animal suffering and to reduce the number of animals used in the experiments. Ethical approval for the human study protocols was obtained from the ethical committees of Tokyo Medical and Dental University (G2020-034). All subjects signed a consent form approved by the ethical committees of Tokyo Medical and Dental University.

  • Open Access

    Trim41 is essential for preventing X chromosome chaotic synapsis in male mice

    by Seiya Oura, Toshiaki Hino, Takashi Satoh, Taichi Noda, Takayuki Koyano, Ayako Isotani, Makoto Matsuyama, Shizuo Akira, Kei-Ichiro Ishiguro, Masahito Ikawa

    Meiosis is a hallmark event in germ cell development that accompanies sequential chromosome events executed by numerous molecules. Therefore, characterization of these factors is one of the best strategies to clarify the mechanism of meiosis. Here, we report tripartite motif-containing 41 (TRIM41), a ubiquitin ligase E3, as an essential factor for proper meiotic progression and fertility in male mice. Trim41 KO spermatocytes exhibited synaptonemal complex protein 3 (SYCP3) overloading, especially on the X chromosome, showing extensive self-synapsis of X chromosome and non-homologous synapsis between the X chromosome and autosomes. Furthermore, the mutant mice lacking the RING domain of TRIM41, required for the ubiquitin ligase E3 activity, phenocopied Trim41 KO mice. We then examined the behavior of mutant TRIM41 (ΔRING-TRIM41) and found that ΔRING-TRIM41 accumulated on the chromosome axes with overloaded SYCP3. This result showed that TRIM41 exerts the function on the chromosome axes. In summary, our study revealed that Trim41 is essential for preventing SYCP3 overloading and chaotic synapsis of the X chromosome, suggesting a TRIM41-mediated mechanism for regulating unsyapsed axes during male meiotic progression. Summary statement: Trim41 -disruption caused abnormal synapsis configuration of the X chromosome and complete infertility in male mice. Thus, TRIM41 prevents the sex chromosome from chaotic synapsis.